NucleoTech Overview
To date, many brain conditions are poorly medicated due to limitations in drug-delivery prevent treating patients efficiently. The prominent reason is the Blood Brain Barrier (BBB), which prevents most therapeutic molecules from reaching the brain – and severely limits the arsenal of brain therapeutics. NucleoTech is developing carriers that deliver a variety of drug-classes across the BBB, including biologics and RNA drugs. The company utilizes the BBBs own transfer mechanisms to allow therapeutic molecules through, by using nanobodies (also called Single Domain Antibodies) as carrier molecules that shuttle therapeutics into the brain by the process of Receptor-Mediated Transcytosis.
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Pre-Funding |
| Rounds | 0 |
| Investors | 0 |
Team Members
1
Employees: 1-10
Web & Social Links
| Website | nucleo-tech.com/ |
Locations
Rehovot, Israel
575 Next Day Hill Dr, Englewood, NJ 07631, USA
Photos & Videos
1 item(s)
NucleoTech Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsCore Technology
BiologicalsMoleculesTags (4)
nanotechnologybrain-disorderpharmaceuticalsdrug-deliveryNucleoTech Financials
NucleoTech Lifecycle
NucleoTech News
0 articlesNo news articles.
NucleoTech Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 7 |
| Team members | 1 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 8 classification IDs that could be used for matching.
NucleoTech Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 88/100 |
| Missing | funding rounds, news, markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 516534476 |
| Creator | Yanina Wainscheinker |
| Creator email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-05-22T00:00:00.000Z |
| Created | 2023-05-22T00:00:00.000Z |